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Preventing Jewish Genetic Diseases in Philadelphia and Nationally
It is estimated that each person is a carrier for
approximately five to 15 recessive mutations in
his or her genes. Since all of our genes come in
pairs – one from our mother and one from our
father – a mutation in one copy is compensated
for by the other copy. Therefore, a carrier for
a recessive genetic disease is a healthy person.
There are usually no outward signs of one’s
carrier status. However, if a carrier for a recessive
disease mates with someone who is also a carrier
for the same recessive disease, then there is a
1 in 4 chance, with each pregnancy, of having
a child affected with that disease.1 Too often,
people find out they are carriers only after a child
is born with a rare recessive disease.

Health Care Network in partnership with Lois
Victor, a mother who lost two children to a Jewish
genetic disease. The Victor Center partners with
college campuses, clergy, healthcare professionals
and communities to build awareness, educate and
provide ongoing access to comprehensive genetic
education, counseling and screening services.

There are many ethnic groups at higher risk
for certain genetic diseases. This may be due to
intermarriage, geographic isolation, or – as is the
case for African Americans, who are at higher
risk for Sickle Cell disease – carrier status offered
protection against acquired diseases more
common in their geographical location. Jews of
Eastern European descent, known as “Ashkenazi
Jews,” are at increased risk to be carriers for
several genetic diseases, many of which are also
found in the general population. These diseases
are severe and many are life-threatening. One
in five Ashkenazi Jews is a carrier for at least
one of 18 diseases2 for which carrier screening
is recommended in the Ashkenazi Jewish
population (Table 1).

The screening program of the Victor Center is
modeled on the community-based screening
movement for Tay-Sachs disease. During
the 1970s, Jewish and medical communities
galvanized around screening for Tay-Sachs
disease and created a powerful grassroots
movement that eventually became standard
medical practice. As a result, the number of
Ashkenazi Jewish babies born with Tay-Sachs
disease has decreased by more than 90%.3
However, many additional diseases have been
identified as having significant carrier frequency
in the Ashkenazi Jewish population since TaySachs screening was started. The Victor Center is
working to raise awareness amongst physicians
of the availability and need for screening for
all 18 diseases through outreach to physician
practices, and providing education at conferences
held by major medical organizations (e.g.,
the National Society of Genetic Counselors,
American College of Medical Genetics and the
American College of Obstetrics and Gynecology).

There are no cures for any of these diseases.
Many lead to early death or shortened lifespans,
and require rigorous daily medical management.
Only one of these diseases, Gaucher disease, has
an effective treatment. However, they can all
be prevented through carrier screening prior to
pregnancy (pre-conception screening). Medically
accurate screening is available with a simple
blood test.
Screening programs have been initiated across the
country in order to reduce the probability of babies
being born with any of these life-threatening and
preventable Jewish genetic diseases (JGD). The
Victor Center for the Prevention of Jewish Genetic
Diseases was founded in 2002 by Albert Einstein

Since the Victor Center was founded in
Philadelphia, Centers have been established at
The Floating Hospital for Children in Boston
and at the University of Miami Miller School of
Medicine. Partnerships are underway in cities
throughout the United States including Atlanta,
Pittsburgh, Minneapolis, Tulsa and Omaha.

The Victor Center approach focuses on prevention
as a fundamental component of social change.
While research continues to search for a cure for
devastating inheritable diseases such as Tay-Sachs,
Canavan, Familial Dysautonomia and others, the
best way to ensure that couples have the greatest
number of reproductive options and that Jewish
children are born free of these diseases, is to
educate our young adults about the diseases and
enable them to know their carrier status. There

Table 1
Genetic Diseases Associated with
Ashkenazi Jews
Bloom Syndrome
Canavan Disease
Cystic Fibrosis
Dihydrolipoamide Dehydrogenase
Deficiency
Familial Dysautonomia
Familial Hyperinsulinism
Fanconi Anemia Type C
Gaucher Disease
Glycogen Storage Disease Type 1A
Joubert Syndrome
Maple Syrup Urine Disease
Mucolipidosis IV
Nemaline Myopathy
Niemann-Pick Disease Type A
Spinal Muscular Atrophy
Tay-Sachs Disease
Usher Syndrome Type IF
Usher Syndrome Type III

are only two ways to find out if you are a carrier:
through a simple blood test or by having an
affected child. Education and awareness must be
followed by screening if we are to have any success
in eradicating these diseases.
The Victor Center is currently involved in several
major projects, including: a pilot education and
screening campaign in Atlanta with the support
of the Marcus Foundation; development of a
webinar to teach Rabbis how to discuss JGDs
with their congregations and young couples;
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working with OB/GYN practices to create a
toolkit for educating both doctors and patients
about Jewish genetic diseases; creating a guide
to ensure appropriate screening; and launching a
video featuring Matisyahu, a Jewish reggae rapper,
educating people about Jewish genetic diseases.
The Victor Center recently completed a three-year
project focused on raising awareness of Jewish
genetic diseases on college campuses. With
funding from the Centers for Disease Control and
Prevention (CDC), the Victor Center hired a social

marketing company to conduct research on the
best practices for educating college students about
Jewish genetic diseases and to empower students
to create a comprehensive awareness campaign
on college campus. The guide and campaign
materials, known as the “1 in 5” campaign, were
field tested at six campuses across the country last
spring. These materials are currently being rolled
out at campuses nationwide. The Victor Center
plans to undertake a similar social marketing
process to identify and create the best practices for
educating young professionals. 

Shoshana Rosen
Outreach Manager
Faye Shapiro, MS, CGC
Genetic Counselor
Victor Center for the Prevention of Jewish Genetic
Diseases
Albert Einstein Medical Center
For more information about the Victor Center
for the Prevention of Jewish Genetic Diseases,
contact Faye Shapiro at shapirof@einstein.edu.

REFERENCES
1. Centre for Genetics Education. Autosomal recessive inheritance pattern. 2007. http://www.genetics.edu.au/pdf/factsheets/fs08.pdf. Accessed May 9, 2011.
2. Pletcher BA, et al. The future is now: Carrier screening for all populations. Genetics Med. 2008: 10(1):54-56. http://journals.lww.com/geneticsinmedicine/Fulltext/2008/01000/The_future_is_now__
carrier_screening_for_all.5.aspx. Accessed May 9, 2011.
3. Kaback MM. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. Eur J Pediatr. 2000; 159:S192-S195.

